During the past decade, Hospital Universitario Lucus Augusti conducted 121 clinical trials. In the 10-year time frame, 121 clinical trials started and 19 clinical trials were completed, i.e. on average, 15.7% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 16 clinical trials were completed. i.e. 24.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Lucus Augusti" #1 sponsor was "Fundación GECP" with 12 trials, followed by "PETHEMA Foundation" with 10 trials sponsored, "Spanish Breast Cancer Research Group" with 10 trials sponsored, "Spanish Oncology Genito-Urinary Group" with 10 trials sponsored and "Fundación EPIC" with 10 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Lucus Augusti" #1 collaborator was "Apices Soluciones S.L." with 6 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator and "Pfizer" with 4 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Lucus Augusti" are "Coronary Artery Disease" (8 trials), "Non Small Cell Lung Cancer" (7 trials), "Lung Cancer" (5 trials), "Breast Cancer" (4 trials) and "Ischemic Heart Disease" (4 trials). Many other conditions were trialed in "Hospital Universitario Lucus Augusti" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Lucus Augusti" are "Drug" (83 trials), "Other" (16 trials), "Biological" (11 trials), "Device" (9 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Carboplatin" (7 trials), "Pembrolizumab" (7 trials), "Cisplatin" (4 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Lucus Augusti" are 117 trials for "All" genders, 11 trials for "Male" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario Lucus Augusti". 1 are not yet recruiting, 43 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Hospital Universitario Lucus Augusti, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Lucus Augusti, 2 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 8 trials that are defined as “Not Applicable".